Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 2onz | TMJ | Phenylethanolamine N-methyltransferase | 2.1.1.28 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 2onz | TMJ | Phenylethanolamine N-methyltransferase | 2.1.1.28 | 1.000 | |
| 2ony | TMJ | Phenylethanolamine N-methyltransferase | 2.1.1.28 | 0.710 | |
| 2opb | F21 | Phenylethanolamine N-methyltransferase | 2.1.1.28 | 0.674 | |
| 2obf | F83 | Phenylethanolamine N-methyltransferase | 2.1.1.28 | 0.587 | |
| 2g72 | F21 | Phenylethanolamine N-methyltransferase | 2.1.1.28 | 0.577 | |
| 2g8n | F83 | Phenylethanolamine N-methyltransferase | 2.1.1.28 | 0.556 | |
| 4li8 | 1XQ | Tankyrase-1 | 2.4.2.30 | 0.472 | |
| 2a9z | 26A | Adenosine kinase | 2.7.1.20 | 0.471 | |
| 3v0o | 4GW | Histo-blood group ABO system transferase | / | 0.470 | |
| 1dgh | NDP | Catalase | 1.11.1.6 | 0.468 | |
| 2bf7 | HBI | Pteridine reductase 1 | 1.5.1.33 | 0.465 | |
| 1zbd | GTP | Ras-related protein Rab-3A | / | 0.462 | |
| 4xbf | FAD | Lysine-specific histone demethylase 1A | 1 | 0.462 | |
| 2ohh | FMN | Type A flavoprotein FprA | 1 | 0.461 | |
| 3ikt | NAD | Redox-sensing transcriptional repressor Rex | / | 0.460 | |
| 4ddr | MMV | Dihydrofolate reductase | 1.5.1.3 | 0.460 | |
| 1v3q | 2DI | Purine nucleoside phosphorylase | 2.4.2.1 | 0.459 | |
| 3g4i | D71 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.459 | |
| 3juo | AJD | Phenazine biosynthesis protein A/B | / | 0.458 | |
| 1olm | VTQ | SEC14-like protein 2 | / | 0.456 | |
| 1ygj | RMC | Pyridoxal kinase | 2.7.1.35 | 0.456 | |
| 3dlc | SAM | SAM (And some other nucleotide) binding motif:Generic methyltransferase | / | 0.456 | |
| 3lm4 | HPX | Catechol 2,3-dioxygenase | / | 0.455 | |
| 1r00 | SAH | Aclacinomycin 10-hydroxylase RdmB | 4.1.1 | 0.454 | |
| 4dvi | 2IW | Tankyrase-1 | 2.4.2.30 | 0.454 | |
| 3hz6 | ADP | Xylulokinase | / | 0.453 | |
| 3zv6 | 4HB | Cis-2,3-dihydrobiphenyl-2,3-diol dehydrogenase | 1.3.1.56 | 0.453 | |
| 4o7u | THF | Thymidylate synthase | / | 0.453 | |
| 4dhy | S41 | Glucokinase | 2.7.1.2 | 0.452 | |
| 4xzj | NAD | Putative NAD(+)--arginine ADP-ribosyltransferase Vis | 2.4.2.31 | 0.452 | |
| 2oci | TYC | Valacyclovir hydrolase | 3.1 | 0.451 | |
| 2rqf | JH3 | Hemolymph juvenile hormone binding protein | / | 0.451 | |
| 3k4s | 0MO | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.451 | |
| 1xoq | ROF | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.450 | |
| 3jun | AKD | Phenazine biosynthesis protein A/B | / | 0.450 | |
| 1std | BFS | Scytalone dehydratase | 4.2.1.94 | 0.448 | |
| 2zev | IPE | Geranylgeranyl pyrophosphate synthase | / | 0.447 | |
| 3h3r | 14H | Collagen type IV alpha-3-binding protein | / | 0.447 | |
| 3ho9 | N3A | 3-oxoacyl-[acyl-carrier-protein] synthase 2 | 2.3.1.179 | 0.447 | |
| 4ddl | 0JQ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.447 | |
| 4jln | 18V | Deoxycytidine kinase | 2.7.1.74 | 0.447 | |
| 1dgf | NDP | Catalase | 1.11.1.6 | 0.446 | |
| 1gw2 | FER | Peroxidase C1A | 1.11.1.7 | 0.446 | |
| 1z6t | ADP | Apoptotic protease-activating factor 1 | / | 0.446 | |
| 3s41 | S41 | Glucokinase | 2.7.1.2 | 0.446 | |
| 1rft | PXM | Pyridoxal kinase | 2.7.1.35 | 0.445 | |
| 1y2c | 3DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.445 | |
| 2j9f | THV | 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial | 1.2.4.4 | 0.445 | |
| 2j9f | THV | 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial | 1.2.4.4 | 0.445 | |
| 3rga | ILD | Epoxide hydrolase LasB | 5.5.1 | 0.445 | |
| 4bb2 | STR | Corticosteroid-binding globulin | / | 0.445 | |
| 4zj8 | SUV | Orexin receptor type 1 | / | 0.445 | |
| 1lcw | SHM | Streptavidin | / | 0.444 | |
| 1oyn | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.444 | |
| 1y2b | DEE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.444 | |
| 2g25 | TDK | Pyruvate dehydrogenase E1 component | 1.2.4.1 | 0.444 | |
| 3dyn | PCG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.444 | |
| 1nhk | CMP | Nucleoside diphosphate kinase | 2.7.4.6 | 0.443 | |
| 3bjc | WAN | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.443 | |
| 3uax | NOS | Purine nucleoside phosphorylase DeoD-type | / | 0.443 | |
| 4ise | 1FW | Glucokinase | 2.7.1.2 | 0.443 | |
| 4kxj | P34 | Nucleoprotein | / | 0.443 | |
| 4tjy | 3GN | Tankyrase-2 | 2.4.2.30 | 0.443 | |
| 1r58 | AO5 | Methionine aminopeptidase 2 | / | 0.442 | |
| 1zkl | IBM | High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 3.1.4.53 | 0.442 | |
| 3aiv | HBO | 4-hydroxy-7-methoxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl glucoside beta-D-glucosidase, chloroplastic | 3.2.1.182 | 0.442 | |
| 3dy8 | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.442 | |
| 3ean | NAP | Thioredoxin reductase 1, cytoplasmic | 1.8.1.9 | 0.442 | |
| 3h3q | H13 | Collagen type IV alpha-3-binding protein | / | 0.442 | |
| 4l5b | 1UX | Deoxycytidine kinase | 2.7.1.74 | 0.442 | |
| 1toi | HCI | Aspartate aminotransferase | 2.6.1.1 | 0.441 | |
| 1yw8 | A75 | Methionine aminopeptidase 2 | / | 0.441 | |
| 3tvx | PNX | cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 3.1.4.53 | 0.441 | |
| 1yry | MSG | Purine nucleoside phosphorylase | 2.4.2.1 | 0.440 | |
| 2fm5 | M99 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.440 | |
| 2zev | B71 | Geranylgeranyl pyrophosphate synthase | / | 0.440 | |
| 3vf6 | 0H6 | Glucokinase | 2.7.1.2 | 0.440 | |
| 4fc0 | 0T2 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.440 | |
| 4fcb | 0T7 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.440 | |
| 4lm4 | JPZ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.440 |